ישראל - עברית - Ministry of Health

unipharm ltd, israel - cilazapril; hydrochlorothiazide - טבליה - cilazapril 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril - טבליה - cilazapril 2.5 mg - cilazapril - cilazapril - treatment of essential hypertension, renal hypertension and chronic heart failure.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril - טבליה - cilazapril 2.5 mg - cilazapril - cilazapril - treatment of essential hypertension, renal hypertension and chronic heart failure.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril - טבליה - cilazapril 5 mg - cilazapril - cilazapril - treatment of essential hypertension, renal hypertension and chronic heart failure.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril - טבליה - cilazapril 5 mg - cilazapril - cilazapril - treatment of essential hypertension, renal hypertension and chronic heart failure.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril as monohydrate; hydrochlorothiazide - טבליה - cilazapril as monohydrate 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - danazol 200 mg - capsules - danazol - treatment of endometriosis amenable to hormonal management, hereditary angioedema.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - solifenacin succinate - טבליה - solifenacin succinate 5 mg - solifenacin - solifenacin - solifenacin is indicated for symptomatic treatment of urge incontinence and/or urinary frequency and urgency as may occur in patients with overactive bladder syndrome.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - solifenacin succinate - טבליה - solifenacin succinate 10 mg - solifenacin - solifenacin - solifenacin is indicated for symptomatic treatment of urge incontinence and/or urinary frequency and urgency as may occur in patients with overactive bladder syndrome.

ישראל - עברית - Ministry of Health

teva israel ltd - filgrastim - תמיסה להזרקה\אינפוזיה - filgrastim 0.6 mg/ml - filgrastim - filgrastim - tevagrastim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. the safety and efficacy of tevagrastim are similar in adults and children receiving cytotoxic chemotherapy. tevagrastim is indicated for the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc). in patients children or adults with severe congenital neutropenia cyclic or idiopathic neutropenia with an absolute nuetrophil count (anc) less than or equal to 0.5 x 1000000000 /l and a history of severe or recurrent infections long term administration of tevagrastim is indicated to increase neutophil count and to red